Patented Medicine Prices Review Board
From Wikipedia, the free encyclopedia
 |
This article or section needs to be wikified to meet Wikipedia's quality standards. Please help improve this article with relevant internal links. (June 2008) |
 |
The neutrality of this article is disputed. Please see the discussion on the talk page.(June 2008) Please do not remove this message until the dispute is resolved. |
The Patented Medicine Prices Review Board is a government agency in Canada which regulates drugs that are still under patent and which yet have no generic substitutes. This Board establishes the maximum prices that can be charged in Canada for patented drugs. [1]
[edit] References
[edit] External links
- http://www.aarpinternational.org/resourcelibrary/resourcelibrary_show.htm?doc_id=547057
- http://pn.psychiatryonline.org/cgi/content/full/38/16/6-a
- http://www.medscape.com/viewarticle/409807_3
- http://www.pmprb-cepmb.gc.ca/english/home.asp?x=1
- http://www.pmprb-cepmb.gc.ca/english/view.asp?x=272
 |
This Canada-related article is a stub. You can help Wikipedia by expanding it. |
 |
This article about a medical organization or association is a stub. You can help Wikipedia by expanding it. |
